您的位置: 首页 > 农业专利 > 详情页

Respiratory disease treatment
专利权人:
Monique Bodil Van Niel;Mohammed Sajad;Harry Finch;Craig Fox;Andrew Forrest
发明人:
Harry Finch,Craig Fox,Mohammed Sajad,Monique Bodil Van Niel,Andrew Forrest
申请号:
US12850318
公开号:
US08236786B2
申请日:
2010.08.04
申请国别(地区):
US
年份:
2012
代理人:
摘要:
There is provided a pharmaceutical composition that is adapted for pulmonary administration by inhalation, which composition comprises a glitazone, such as pioglitazone or rosiglitazone, and one or more pharmaceutically acceptable carriers and/or excipients, and wherein the glitazone content of the composition consists of at least 95% by weight of the 5R enantiomer and less than 5% by weight of the 5S enantiomer. There is also provided a use and kit.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充